CanSino Biologics Inc
SSE:688185
CanSino Biologics Inc
SSE:688185
Price:
68.93
CNY
3.28%
Market Closed
Market Cap:
¥11.2B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
CanSino Biologics Inc
SSE:688185
|
CN |
|
Mitsubishi Heavy Industries Ltd
TSE:7011
|
JP |
|
T
|
Tonghua Dongbao Pharmaceutical Co Ltd
SSE:600867
|
CN |
|
H
|
HeNan Splendor Science & Technology Co Ltd
SZSE:002296
|
CN |
Income Statement
Earnings Waterfall
CanSino Biologics Inc
CanSino Biologics Inc
Income Statement
CanSino Biologics Inc
CanSino Biologics Inc
Currency: CNY
| Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||||||||||||||||||||
| Interest Expense |
0
|
0
|
0
|
0
|
0
|
0
|
7
|
12
|
20
|
30
|
29
|
36
|
41
|
68
|
0
|
67
|
64
|
50
|
68
|
66
|
60
|
58
|
0
|
0
|
0
|
|
| Revenue |
0
N/A
|
4
N/A
|
4
N/A
|
6
+41%
|
19
+227%
|
487
+2 526%
|
2 082
+327%
|
3 104
+49%
|
4 300
+39%
|
4 332
+1%
|
2 868
-34%
|
1 921
-33%
|
1 035
-46%
|
636
-39%
|
531
-16%
|
603
+14%
|
357
-41%
|
471
+32%
|
635
+35%
|
749
+18%
|
846
+13%
|
869
+3%
|
925
+6%
|
972
+5%
|
1 068
+10%
|
|
| Gross Profit | ||||||||||||||||||||||||||
| Cost of Revenue |
0
|
(0)
|
0
|
(2)
|
(14)
|
(241)
|
(645)
|
(1 069)
|
(1 298)
|
(1 231)
|
(896)
|
(498)
|
(1 218)
|
(343)
|
(365)
|
(425)
|
(801)
|
(316)
|
(271)
|
(242)
|
(257)
|
(193)
|
(191)
|
(206)
|
(264)
|
|
| Gross Profit |
0
N/A
|
4
N/A
|
0
N/A
|
4
N/A
|
5
+16%
|
246
+5 099%
|
1 436
+483%
|
2 035
+42%
|
3 002
+47%
|
3 101
+3%
|
1 972
-36%
|
1 423
-28%
|
(184)
N/A
|
293
N/A
|
167
-43%
|
178
+7%
|
(444)
N/A
|
156
N/A
|
363
+133%
|
507
+39%
|
589
+16%
|
677
+15%
|
734
+8%
|
766
+4%
|
804
+5%
|
|
| Operating Income | ||||||||||||||||||||||||||
| Operating Expenses |
(201)
|
(243)
|
(262)
|
(356)
|
(413)
|
(775)
|
(1 026)
|
(1 139)
|
(1 203)
|
(1 144)
|
(1 146)
|
(1 733)
|
(1 274)
|
(2 072)
|
(2 983)
|
(2 465)
|
(1 245)
|
(2 328)
|
(1 241)
|
(1 175)
|
(937)
|
(931)
|
(929)
|
(951)
|
(790)
|
|
| Selling, General & Administrative |
(66)
|
(82)
|
(80)
|
(106)
|
(96)
|
(147)
|
(210)
|
(274)
|
(326)
|
(408)
|
(440)
|
(487)
|
(545)
|
(569)
|
(725)
|
(700)
|
(621)
|
(746)
|
(580)
|
(586)
|
(535)
|
(575)
|
(594)
|
(634)
|
(580)
|
|
| Research & Development |
(137)
|
(171)
|
(217)
|
(286)
|
(409)
|
(735)
|
(921)
|
(956)
|
(851)
|
(766)
|
(651)
|
(772)
|
(731)
|
(771)
|
(942)
|
(841)
|
(568)
|
(735)
|
(486)
|
(449)
|
(336)
|
(392)
|
(378)
|
(369)
|
(237)
|
|
| Depreciation & Amortization |
(17)
|
(22)
|
(26)
|
0
|
(23)
|
0
|
0
|
0
|
(40)
|
0
|
0
|
0
|
(55)
|
0
|
0
|
0
|
(112)
|
0
|
0
|
0
|
(115)
|
0
|
0
|
0
|
(99)
|
|
| Other Operating Expenses |
19
|
31
|
62
|
36
|
114
|
108
|
104
|
91
|
14
|
31
|
(55)
|
(474)
|
58
|
(731)
|
(1 316)
|
(924)
|
55
|
(848)
|
(176)
|
(140)
|
48
|
36
|
43
|
52
|
126
|
|
| Operating Income |
(201)
N/A
|
(239)
-19%
|
(258)
-8%
|
(352)
-37%
|
(409)
-16%
|
(528)
-29%
|
410
N/A
|
896
+118%
|
1 798
+101%
|
1 957
+9%
|
826
-58%
|
(310)
N/A
|
(1 458)
-370%
|
(1 779)
-22%
|
(2 817)
-58%
|
(2 286)
+19%
|
(1 689)
+26%
|
(2 172)
-29%
|
(878)
+60%
|
(668)
+24%
|
(348)
+48%
|
(254)
+27%
|
(195)
+24%
|
(185)
+5%
|
14
N/A
|
|
| Pre-Tax Income | ||||||||||||||||||||||||||
| Interest Income Expense |
44
|
16
|
46
|
20
|
11
|
37
|
74
|
121
|
142
|
122
|
238
|
310
|
277
|
284
|
243
|
143
|
115
|
61
|
(46)
|
(76)
|
50
|
37
|
28
|
41
|
16
|
|
| Non-Reccuring Items |
(0)
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
(363)
|
0
|
0
|
0
|
(77)
|
1
|
1
|
1
|
(7)
|
|
| Gain/Loss on Disposition of Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Other Income |
(0)
|
43
|
(0)
|
46
|
(0)
|
5
|
(16)
|
(21)
|
(4)
|
(5)
|
(5)
|
(0)
|
(3)
|
(10)
|
(52)
|
(51)
|
(43)
|
(42)
|
(1)
|
(5)
|
(6)
|
(6)
|
(6)
|
(4)
|
(2)
|
|
| Pre-Tax Income |
(157)
N/A
|
(180)
-15%
|
(212)
-18%
|
(286)
-35%
|
(397)
-39%
|
(486)
-23%
|
469
N/A
|
996
+112%
|
1 937
+94%
|
2 073
+7%
|
1 058
-49%
|
(0)
N/A
|
(1 184)
-259 720%
|
(1 505)
-27%
|
(2 626)
-74%
|
(2 194)
+16%
|
(1 979)
+10%
|
(2 154)
-9%
|
(925)
+57%
|
(749)
+19%
|
(381)
+49%
|
(223)
+42%
|
(171)
+23%
|
(147)
+14%
|
22
N/A
|
|
| Net Income | ||||||||||||||||||||||||||
| Tax Provision |
0
|
0
|
0
|
0
|
0
|
0
|
100
|
44
|
(30)
|
(36)
|
(72)
|
85
|
219
|
256
|
193
|
93
|
11
|
0
|
9
|
9
|
(2)
|
3
|
4
|
5
|
6
|
|
| Income from Continuing Operations |
(157)
|
(180)
|
(212)
|
(286)
|
(397)
|
(486)
|
569
|
1 039
|
1 907
|
2 037
|
986
|
85
|
(965)
|
(1 249)
|
(2 433)
|
(2 101)
|
(1 967)
|
(2 142)
|
(915)
|
(740)
|
(384)
|
(220)
|
(167)
|
(142)
|
28
|
|
| Income to Minority Interest |
0
|
0
|
0
|
0
|
0
|
2
|
0
|
0
|
7
|
13
|
3
|
22
|
55
|
79
|
531
|
542
|
485
|
489
|
49
|
20
|
5
|
0
|
0
|
0
|
0
|
|
| Net Income (Common) |
(157)
N/A
|
(180)
-15%
|
(212)
-18%
|
(286)
-35%
|
(397)
-39%
|
(484)
-22%
|
569
N/A
|
1 039
+83%
|
1 914
+84%
|
2 050
+7%
|
989
-52%
|
106
-89%
|
(909)
N/A
|
(1 170)
-29%
|
(1 903)
-63%
|
(1 560)
+18%
|
(1 483)
+5%
|
(1 653)
-11%
|
(867)
+48%
|
(720)
+17%
|
(379)
+47%
|
(220)
+42%
|
(167)
+24%
|
(142)
+15%
|
28
N/A
|
|
| EPS (Diluted) |
-0.77
N/A
|
-0.8
-4%
|
-0.95
-19%
|
-1.24
-31%
|
-1.72
-39%
|
-2.07
-20%
|
2.29
N/A
|
4.19
+83%
|
7.74
+85%
|
8.29
+7%
|
4
-52%
|
0.43
-89%
|
-3.68
N/A
|
-4.78
-30%
|
-7.71
-61%
|
-6.32
+18%
|
-6.01
+5%
|
-6.67
-11%
|
-3.51
+47%
|
-2.92
+17%
|
-1.53
+48%
|
-0.89
+42%
|
-0.57
+36%
|
-0.77
-35%
|
0.11
N/A
|
|
Switch to:
Switch to:
See Also
Discover More
